Flt-3 ligand does not induce the growth of peripheral blood granulocyte- macrophage colony-forming cells in myeloproliferative disorders

European Journal of Haematology

Volumn 62, Issue 2, 1999, Pages 103-108

  Siitonen, Timo ^a   Savolainen, E R ^a   Koistinen, P ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

CFU GM; Colony assay; Flt 3 ligand; MPDs

Indexed keywords

FLT3 LIGAND; GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032909742     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01729.x     Document Type: Article

References (36)

1. LYMAN SD, JAMES L, ZAPPONE J, SLEATH PR, BECKMANN MP, BIRD T. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene. Oncogene 1993;8:815-822.
2. ROSNET O, STEPHENSON D, MATTEI M-G. Close physical linkage of the flt1 and flt3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 1993;8:173-179.
3. LYMAN SD, JAMES L, JOHNSON L. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993;75:1157-1167.
4. HANNUM C, CULPEPPER J, CAMPBELI D. Ligand for flt3/flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 1994;368:643-648.
5. LYMAN SD, JAMES L, JOHNSON L. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994;83:2795-2801.
6. PIACIBELLO W, FUBINI L, SANAVIO F. Effects of human flt3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1995;86:4105-4114.
7. GABBIANELLI M, PELOSI E, MONTESORA E. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 1995;86:1661-1670.
8. BRASUEM-STEIN C, FLOWERS DA, BERNSTEIN ID. Regulation of colony forming cell generation by flt-3 ligand. Br J Haematol 1996;94:17-22.
9. - cells and maintains progenitor cells in vitro. Blood 1996;87:3563-3570.
10. BRASEL K, MCKENNA HJ, CHARRIER K, MORRISSEY PJ, WILLIAMS DE, LYMAN SD. Flt3 ligand synergizes with granulocyle-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 1997;90:3781-3788.
11. MOLINEUX G, MCCREA C, YAN XQ, KERZIC P, MCNIECE I. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and mobilize peripheral blood stem cells with long-term repopulating potential. Blood 1997;89:3998-4004.
12. GOLDMAN JM, SCHMITZ N, NIETHAMMER D, GRATWOHL A, FOR THE ACCREDITATION SUB-COMMITTEE OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998;21:1-7.
13. BIRG F, COURCOUL M, ROSNET O. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992;80:2584-2593.
14. CAROW CE, LEVENSTEIN M, KAUFMANN SH. Expression of the hematopoietic growth factor receptor flt3 (stk-1/flk2) in human leukemias. Blood 1996;97:1089-1096.
15. ROSNET O, BÜRING H-I, MARCHETTO S. Human flt3/flk2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996;10:238-248.
16. STACCHINI A, FUBINI L, SEVERINO A, AGLIETTA M, PIACIBELLO W. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. Leukemia 1996;10:1584-1591.
17. BHATIA R, VERFAILLIE CM, MILLER JS, MCGLAVE PB. Autologous transplantation therapy for chronic myelogenous leukemia. Blood 1997;89:2623-2634.
18. WASSERMAN LR. The management of polycythaemia vera. Br J Haematol 1971;21:371-376.
19. ROWLEY JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-293.
20. HOFFMAN R, SILVERSTEIN MN. Primary thrombocythemia In: HOFFMAN R, BENTZ Jr EJ, SHATTIL SJ, FURIE B, COHEN HJ, eds. Hematology, basic principles and practice. New York: Churchill Livingstone, 1991:881-889.
21. BOYUM A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;21(suppl 97):77-89.
22. ROGERS SY, BRADBURY DA, RUSSEL NH. Colony-forming assays for acute myeloid leukemia In: FRESHNEY RI, PRAGNELL IB, FRESNEY MG, eds. Culture of hematopoietic cells. New York: Wiley-Liss Inc, 1994:99-102.
23. ADAMSON JW. Analysis of haemopoiesis: the use of cell markers and in vitro culture techniques in studies of clonal haemopathies in man. Clin Haematol 1986;13:489-503.
24. LOWENBERG B, Touw IP. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993;81:281-292.
25. PRCHAL JF, ADAMSON JW, MURPHY S, STEINMANN L, FIALKOW PJ. Polycythemia vera: the in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest 1978;61:1044-1047.
26. DIAMOND J, GOLDMAN JM, MELO JV. BCR-ABL, ABL-BCR, BCR and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood 1995;85:2171-2175.
27. RUUTU T. In vitro culture of hematopoietic progenitors in the diagnosis of blood disorders. Leuk Res 1992;16:423-426.
28. SITTONEN T, ZHENG A, SAVOLAINEN E-R, KOISTINEN P. Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders. Leuk Res 1996;20:187-195.
29. GREENBERG PL. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin Haematol 1986;15:973-993.
30. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994;91:459-463.
31. RAPPOLD I, ZIEGLER BL, KÖHLER I. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 1997;90:111-125.
32. MEIERHOFF G, DEHMEL U, GRUSS H-J. Expression of FLT3 receptor and FLT-ligand in human leukemia-lymphoma cell lines. Leukemia 1995;9:1368-1372.
33. HOHAUS S, VOSO MT, HAAS R. The role of cytokines in the mobilization of blood stem cells In: REIFFERS J, GOLDMAN J, ARMITAGE JO, eds. Blood stem cell transplantation. London: Martin Dunitz Ltd, 1998:37-54.
34. DAI CH, KRANTZ SB, DESSYPRIS EN, MEANS RT, HORN ST, GILBERT HS. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony stimulating factor. Blood 1992;80:891-899.
35. MAZE R, HORIE M, HENDRIE P. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Exp Hematol 1993;21:545-551.
36. SHTONEN T, ZHENG A, SAVOLAINEN E-R, KOISTINEN P. The effect of mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in methylcellulose in myeloproliferative disorders. Eur J Haematol 1995;55:228-234.